An Integrated Theory of the No-Reflow Phenomenon and the Beneficial Effect of Vascular Washout on No-Reflow
Authors:
- 1 April 1999
- journal article
- research article
- Published by Wiley in The Laryngoscope
- Vol. 109 (4) , 528-535
Abstract
Objectives: No-reflow is failure of perfusion in free tissue transfer despite adequate arterial inflow. The objectives of this study were to construct a theory of interactive mechanisms of the no-reflow phenomenon and to determine whether preischemic vascular washout could increase flap ischemia tolerance. Study Design: The evidence for the role of various mechanisms in the development of no-reflow is reviewed, and an integrated network proposed. A ratgroin free flap model is used to test preischemic vascular washout with normal saline, heparinized normal saline, lactated Ringer's solution, Tis-U-Sol, and Viaspan. Methods: The mean ischemia tolerance of this flap without any therapeutic intervention was first determined, using 22 animals. An additional 50 animals were used to compare with the control group the ischemia tolerance of flaps washed out with the above fluids before their ischemic period. Results: The critical ischemia time 50 (time after which half of the flaps are expected to survive and half, die) of the untreated flap is 23.4 hours in this model (P < .05). Flaps washed out with normal saline or lactated Ringer's solution have significantly worse ischemia tolerance (P < .0001). Flaps washed out with Tis-U-Sol or Viaspan behave similarly to the control group (P > .57). Flaps receiving preischemic washout with heparinized normal saline (4,000 units/L) had a significantly better outcome than the control group (P < .027). Conclusions: Preischemic washout with normal saline, lactated Ringer's solution, or heparinized Tis-U-Sol is detrimental for flap survival after ischemia, Tis-U-Sol- and Viaspan-treated flaps do have ischemia tolerance similar to the control group, and flaps washed out with heparinized normal saline have a survival advantage in this model.Keywords
This publication has 52 references indexed in Scilit:
- Efficacy of Recombinant Human Manganese Superoxide Dismutase Compared to Allopurinol in Protection of Ischemic Skeletal Muscle Against “No-Reflow”Journal of Reconstructive Microsurgery, 1995
- Free flap survival improved by prostacyclin analoguesMicrosurgery, 1993
- Temporal Factors Affecting the Secondary Critical Ischemia of Normothermic Experimental Skin FlapsJAMA Otolaryngology–Head & Neck Surgery, 1991
- Ischemia-Induced Reperfusion Injury in Muscle Flaps: Pathogenesis and Major Source of Free RadicalsJournal of Reconstructive Microsurgery, 1990
- Perfusion Washout: Increasing a Microvascular Free Flap Tolerance to IschemiaJournal of Reconstructive Microsurgery, 1989
- Improved Ischemic Island Skin Flap Survival with Continuous Intraarterial Infusion of Adenosine Triphosphate—Magnesium Chloride and Superoxide Dismutase: A Rat ModelAnnals of Plastic Surgery, 1987
- Calcium-accentuated ischemic damage during reperfusion: The time course of the reperfusion injury in the isolated working rat heart modelJournal of Surgical Research, 1987
- The role of oxygen-derived free radicals in ischemia-induced increases in canine skeletal muscle vascular permeability.Circulation Research, 1985
- Oxygen-Derived Free Radicals in Postischemic Tissue InjuryNew England Journal of Medicine, 1985
- MECHANISM OF ACTION OF WASHOUT SOLUTIONS FOR KIDNEY PRESERVATIONTransplantation, 1973